Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hardy-Bessard, Anne-claire
78  Ergebnisse:
Personensuche X
?
1

CHEOPS trial: a GINECO group randomized phase II assessing ..:

Bailleux, Caroline ; Arnaud, Antoine ; Frenel, Jean-Sébastien...
Breast Cancer.  30 (2023)  2 - p. 315-328 , 2023
Link: https://doi.org/10.1007/..
 
?
2

Recommandations pour la pratique clinique Nice/Saint-Paul-d..:

Martínez, Alejandra ; Chargari, Cyrus ; Kalbacher, Elsa...
Bulletin du Cancer.  110 (2023)  6 - p. 6S20-6S33 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Effective treatment based on monitoring bESR1 mutations – A..:

Bidard, Francois-Clément ; Hardy-Bessard, Anne-Claire ; Delaloge, Suzette
The Lancet Oncology.  24 (2023)  1 - p. e4 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Updated progression-free survival and final overall surviva..:

Lorusso, Domenica ; Mouret-Reynier, Marie-Ange ; Harter, Philipp...
International Journal of Gynecologic Cancer.  34 (2023)  4 - p. 550-558 , 2023
Link: https://doi.org/10.1136/..
 
?
5

Rucaparib for the Treatment of Metastatic Castration-resist..:

Abida, Wassim ; Campbell, David ; Patnaik, Akash...
European Urology.  84 (2023)  3 - p. 321-330 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Paclitaxel with or without pazopanib for ovarian cancer rel..:

Joly, Florence ; Fabbro, Michel ; Berton, Dominique...
Gynecologic Oncology.  166 (2022)  3 - p. 389-396 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Real-Time Detection of ESR1 Mutation in Blood by Droplet Di..:

Callens, Celine ; Bidard, Francois-Clement ; Curto-Taribo, Anaïs...
Analytical Chemistry.  94 (2022)  16 - p. 6297-6303 , 2022
Link: https://doi.org/10.1021/..
 
?
8

Regorafenib or Tamoxifen for platinum-sensitive recurrent o..:

Trédan, Olivier ; Provansal, Magali ; Abdeddaim, Cyril...
Gynecologic Oncology.  164 (2022)  1 - p. 18-26 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Randomised, open-label, multicentric phase III trial to eva..:

Berger, Frédérique ; Marce, Margaux ; Delaloge, Suzette...
BMJ Open.  12 (2022)  3 - p. e055821 , 2022
Link: https://doi.org/10.1136/..
 
?
10

Efficacy of maintenance olaparib plus bevacizumab according..:

Harter, Philipp ; Mouret-Reynier, Marie Ange ; Pignata, Sandro...
Gynecologic Oncology.  164 (2022)  2 - p. 254-264 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Phase II study of the safety and efficacy of the anti-PD-1 ..:

O'Malley, David M. ; Oaknin, Ana ; Monk, Bradley J....
Gynecologic Oncology.  163 (2021)  2 - p. 274-280 , 2021
Link: https://doi.org/10.1016/..
 
?
12

Erratum to 'Clinical progression is associated with poor pr..:

Delanoy, Nicolas ; Hardy-Bessard, Anne-Claire ; Efstathiou, Eleni...
European Journal of Cancer.  137 (2020)  - p. 290-291 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Corrigendum to "Clinical progression is associated with poo..:

Delanoy, Nicolas ; Hardy-Bessard, Anne-Claire ; Efstathiou, Eleni...
European Journal of Cancer.  137 (2020)  - p. 288-289 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Risk factors for Coronavirus Disease 2019 (COVID-19) severi..:

Lièvre, Astrid ; Turpin, Anthony ; Ray-Coquard, Isabelle...
European Journal of Cancer.  141 (2020)  - p. 62-81 , 2020
Link: https://doi.org/10.1016/..
 
?
15

First-line bevacizumab and eribulin combination therapy for..:

Hardy-Bessard, Anne-Claire ; Brocard, Fabien ; Clatot, Florian...
The Breast.  54 (2020)  - p. 256-263 , 2020
Link: https://doi.org/10.1016/..
 
1-15